MMI-0100, a cell-permeant peptide inhibitor of mitogen-activated protein kinase activated protein kinase II (MK2), effectively reduces intimal hyperplasia ex vivo and in vivo. It specifically suppresses IL-6 expression while not affecting IL-8 expression and mitigates fibrotic processes, including vein graft disease [1].
Molecular Weight:
2283.64
CAS Number:
[1039342-24-9]
Formula:
C98H171N37O26
Target:
MAPK
T76242
* VAT and and shipping costs not included. Errors and price changes excepted
